Drugs Approved for Colon and Rectal Cancer
This page lists cancer drugs approved by the Food and Drug Administration (FDA) for colon and rectal cancer. The list includes generic and brand names. This page also lists common drug combinations used in colon and rectal cancer. The individual drugs in the combinations are FDA-approved. However, the drug combinations themselves usually are not approved, although they are widely used.
The drug names link to NCI's Cancer Drug Information summaries. There may be drugs used in colon cancer and rectal cancer that are not listed here.
On this page:
Drugs Approved for Colon Cancer
- Adrucil (Fluorouracil)
- Avastin (Bevacizumab)
- Bevacizumab
- Camptosar (Irinotecan Hydrochloride)
- Capecitabine
- Cetuximab
- Efudex (Fluorouracil)
- Eloxatin (Oxaliplatin)
- Erbitux (Cetuximab)
- Fluoroplex (Fluorouracil)
- Fluorouracil
- Irinotecan Hydrochloride
- Leucovorin Calcium
- Oxaliplatin
- Panitumumab
- Regorafenib
- Stivarga (Regorafenib)
- Vectibix (Panitumumab)
- Wellcovorin (Leucovorin Calcium)
- Xeloda (Capecitabine)
- Zaltrap (Ziv-Aflibercept)
- Ziv-Aflibercept
Drug Combinations Used in Colon Cancer
Drugs Approved for Rectal Cancer
- Adrucil (Fluorouracil)
- Avastin (Bevacizumab)
- Bevacizumab
- Camptosar (Irinotecan Hydrochloride)
- Cetuximab
- Efudex (Fluorouracil)
- Erbitux (Cetuximab)
- Fluoroplex (Fluorouracil)
- Fluorouracil
- Irinotecan Hydrochloride
- Panitumumab
- Regorafenib
- Stivarga (Regorafenib)
- Vectibix (Panitumumab)
- Zaltrap (Ziv-Aflibercept)
- Ziv-Aflibercept
Back to Top